PharVision Advisers’s Deluxe DLX Stock Holding History

PharVision Advisers’s Portfolio DLX Stock Details DLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,941	Closed	-$173K	–	306
2025 Q1	$173K	Buy	+10,941	New	+$207K	0.24%	216

Other funds holding DLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

PharVision Advisers's DLX Position: Q2 2025 in Review

PharVision Advisers sold out of Deluxe (DLX) in Q2 2025, closing a stake of 10,941 shares — an estimated $173K sold.

PharVision Advisers first reported a position in DLX in Q1 2025 and held it in 1 quarter. The position peaked at $173K in Q1 2025. 203 funds tracked by Wall St. Rank hold DLX as of Q2 2025.

PharVision Advisers reported no remaining Deluxe position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 10,941 Deluxe shares in Q2 2025, an estimated $173K.
PharVision Advisers first reported a position in Deluxe in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Deluxe position peaked at $173K in Q1 2025.
203 funds tracked by Wall St. Rank held Deluxe as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.